EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 14.10
-0.10 (-0.70%)
Apr 29, 2026, 1:30 PM CST
EPS Bio Technology Revenue
In the year 2025, EPS Bio Technology had annual revenue of 499.70M TWD with 10.78% growth. EPS Bio Technology had revenue of 119.21M in the quarter ending December 31, 2025, with 2.16% growth.
Revenue
499.70M
Revenue Growth
+10.78%
P/S Ratio
0.68
Revenue / Employee
4.58M
Employees
109
Market Cap
337.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 499.70M | 48.62M | 10.78% |
| Dec 31, 2024 | 451.08M | -19.08M | -4.06% |
| Dec 31, 2023 | 470.17M | 6.72M | 1.45% |
| Dec 31, 2022 | 463.45M | -16.83M | -3.50% |
| Dec 31, 2021 | 480.28M | 2.68M | 0.56% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Taiwan Advanced Nanotech | 154.37M |
| Health & Life | 398.05M |
| iXensor | 26.88M |
| AmCad BioMed | 30.44M |
| Radiant Innovation | 387.58M |
| S&S Healthcare Holding | 204.21M |
| PlexBio | 127.10M |
| Wiltrom | 311.77M |